Analyst Undervalued Stocks on the NAS October 2024

October 14, 2024

Analyst Undervalued

Companies on this list are considered undervalued based on the analyst consensus. This means that the average analyst target price is greater than the close price.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

About the Data

This table includes the close price and analyst target price mean from most recent available data. The fiscal year indicates the year for the analyst target price, as the target may not always be for the current year. The number of estimates indicates the number of analyst targets used to calculate the target price mean.

How do you use this table?

Analysts believe that the companies on this list will see the close price move up to their target price mean by the target year indicated. Companies with a large analyst following or large difference between close price and target price are particularly interesting to investigate further. This becomes a starting point for further analysis to understand why these companies are undervalued. Stocks in this category are generally held for capital appreciation or dividends.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose PriceTarget Price MeanTarget YearNumber of EstimatesCurrency
MSFT Microsoft Corp 416.32 500.33 2025 7 USD
ADBE Adobe Inc 495.42 597.00 2025 7 USD
INTU Intuit Inc 616.68 709.00 2025 3 USD
REGN Regeneron Pharmaceuticals Inc 1015.67 1213.00 2025 5 USD
MELI MercadoLibre Inc 2091.16 2300.00 2025 1 USD
SNPS Synopsys Inc 539.92 640.00 2025 1 USD
COIN Coinbase Global Inc 176.38 270.40 2025 5 USD
FCNCA First Citizens BancShares Inc 2021.10 2200.00 2025 1 USD
BIIB Biogen Inc 188.38 272.40 2025 5 USD
FSLR First Solar Inc 211.49 329.20 2025 5 USD
All data provided as at market close October 13, 2024.

Company Details

Microsoft Corp

MSFT:NAS

Close Price

416.32

Target Price Mean

500.33

Target Year

2025

Target Price # Estimates

7

Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite.

Access the stockcalc valuation


Adobe Inc

ADBE:NAS

Close Price

495.42

Target Price Mean

597.00

Target Year

2025

Target Price # Estimates

7

Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).

Access the stockcalc valuation


Intuit Inc

INTU:NAS

Close Price

616.68

Target Price Mean

709.00

Target Year

2025

Target Price # Estimates

3

Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of US market share for small-business accounting and do-it-yourself tax-filing software.

Access the stockcalc valuation


Regeneron Pharmaceuticals Inc

REGN:NAS

Close Price

1015.67

Target Price Mean

1213.00

Target Year

2025

Target Price # Estimates

5

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

MercadoLibre Inc

MELI:NAS

Close Price

2091.16

Target Price Mean

2300.00

Target Year

2025

Target Price # Estimates

1

MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions as of the end of 2023.

Access the stockcalc valuation


Synopsys Inc

SNPS:NAS

Close Price

539.92

Target Price Mean

640.00

Target Year

2025

Target Price # Estimates

1

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality.

Access the stockcalc valuation


Coinbase Global Inc

COIN:NAS

Close Price

176.38

Target Price Mean

270.40

Target Year

2025

Target Price # Estimates

5

Founded in 2012, Coinbase is the leading cryptocurrency exchange platform in the United States. The company intends to be the safe and regulation-compliant point of entry for retail investors and institutions into the cryptocurrency economy. Users can establish an account directly with the firm, instead of using an intermediary, and many choose to allow Coinbase to act as a custodian for their cryptocurrency, giving the company breadth beyond that of a traditional financial exchange.

Access the stockcalc valuation


First Citizens BancShares Inc

FCNCA:NAS

Close Price

2021.10

Target Price Mean

2200.00

Target Year

2025

Target Price # Estimates

1

First Citizens BancShares Inc is the bank holding company of First Citizens Bank & Trust Company. FCB was founded as the Bank of Smithfield in North Carolina and has expanded through both de novo branching and acquisitions. FCB currently operates in nearly half of the continental United States, but principally takes deposits in the Carolinas.

Access the stockcalc valuation


Biogen Inc

BIIB:NAS

Close Price

188.38

Target Price Mean

272.40

Target Year

2025

Target Price # Estimates

5

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity.

Access the stockcalc valuation


First Solar Inc

FSLR:NAS

Close Price

211.49

Target Price Mean

329.20

Target Year

2025

Target Price # Estimates

5

First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Microsoft and Adobe are among the most undervalued NAS stocks this month. See the most undervalued companies on the blog: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nas-october-2024
Microsoft $MSFT and Adobe $ADBE on the #NAS among the most undervalued this month. See the full list of undervalued companies: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nas-october-2024
Microsoft and Adobe are among the most undervalued NAS stocks this month. See the most undervalued companies on the blog: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nas-october-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.